Terms: = Lung cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Prognosis
20 results:
1. The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.
Karaağaç M; Geredeli Ç; Yıldırım MS; Altınok T; Dede İ; İnal A; Zamani AG; Kaya B; Demirkazık A; Artaç M
J Cancer Res Ther; 2023; 19(5):1248-1254. PubMed ID: 37787291
[TBL] [Abstract] [Full Text] [Related]
2. Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of
Wu WY; Jiao X; Song WX; Wu P; Xiao PQ; Huang XF; Wang K; Zhan SF
Front Endocrinol (Lausanne); 2023; 14():1187882. PubMed ID: 37347115
[TBL] [Abstract] [Full Text] [Related]
3. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Fei Jin Sheng Formula in the Treatment of lung cancer.
Zhang YC; Gao WC; Chen WJ; Pang DX; Mo DY; Yang M
Curr Pharm Des; 2023; 29(14):1121-1134. PubMed ID: 37138492
[TBL] [Abstract] [Full Text] [Related]
4. Response to Standard Therapies and Comprehensive Genomic Analysis for Patients with lung Adenocarcinoma with
Choudhury NJ; Schoenfeld AJ; Flynn J; Falcon CJ; Rizvi H; Rudin CM; Kris MG; Arcila ME; Heller G; Yu HA; Ladanyi M; Riely GJ
Clin Cancer Res; 2021 May; 27(10):2920-2927. PubMed ID: 33685865
[TBL] [Abstract] [Full Text] [Related]
5. Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.
Pérez-Ramírez C; Cañadas-Garre M; Alnatsha A; Villar E; Valdivia-Bautista J; Faus-Dáder MJ; Calleja-Hernández MÁ
Pharmacogenomics J; 2019 Apr; 19(2):164-177. PubMed ID: 29662106
[TBL] [Abstract] [Full Text] [Related]
6. Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer.
Pérez-Ramírez C; Cañadas-Garre M; Molina MÁ; Robles AI; Faus-Dáder MJ; Calleja-Hernández MÁ
Mutat Res Rev Mutat Res; 2017; 771():32-58. PubMed ID: 28342452
[TBL] [Abstract] [Full Text] [Related]
7. Correlation between gene polymorphisms of CYP1A1, GSTP1, ercc2, XRCC1, and XRCC3 and susceptibility to lung cancer.
Liu HX; Li J; Ye BG
Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27819744
[TBL] [Abstract] [Full Text] [Related]
8. The genetic variations in DNA repair genes ercc2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
Wang S; Wang J; Bai Y; Wang Q; Liu L; Zhang K; Hong X; Deng Q; Zhang X; He M; Wu T; Xu P; Guo H
Cancer Med; 2016 Sep; 5(9):2332-42. PubMed ID: 27465648
[TBL] [Abstract] [Full Text] [Related]
9. DNA Repair Gene Polymorphisms in Relation to Non-Small Cell lung cancer Survival.
Su Y; Zhang H; Xu F; Kong J; Yu H; Qian B
Cell Physiol Biochem; 2015; 36(4):1419-29. PubMed ID: 26159902
[TBL] [Abstract] [Full Text] [Related]
10. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.
Du Y; Su T; Zhao L; Tan X; Chang W; Zhang H; Cao G
PLoS One; 2014; 9(6):e99843. PubMed ID: 24933103
[TBL] [Abstract] [Full Text] [Related]
11. Predictive effect of XPA and xpd polymorphisms on survival of advanced NSCLC patients treated with platinum-based chemotherapy: a three-dimensional (3-D), polyacrylamide gel-based DNA microarray method.
Cheng H; Qin Q; Sun X; Li F; Sun N; Cheng L; Lu Z; Chen B
Technol Cancer Res Treat; 2013 Oct; 12(5):473-82. PubMed ID: 23617284
[TBL] [Abstract] [Full Text] [Related]
12. Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy.
Butkiewicz D; Drosik A; Suwiński R; Krześniak M; Rusin M; Kosarewicz A; Rachtan J; Matuszczyk I; Gawkowska-Suwińska M
Int J Cancer; 2012 Oct; 131(7):E1100-8. PubMed ID: 22511383
[TBL] [Abstract] [Full Text] [Related]
13. Effect of polymorphisms in xpd on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients.
Wu W; Li H; Wang H; Zhao X; Gao Z; Qiao R; Zhang W; Qian J; Wang J; Chen H; Wei Q; Han B; Lu D
PLoS One; 2012; 7(3):e33200. PubMed ID: 22479369
[TBL] [Abstract] [Full Text] [Related]
14. Association of XRCC3 and xpd751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patients.
Chen X; Sun H; Ren S; Kim Curran V; Zhang L; Zhou S; Zhang J; Zhou C
Clin Transl Oncol; 2012 Mar; 14(3):207-13. PubMed ID: 22374424
[TBL] [Abstract] [Full Text] [Related]
15. Association of cytidine deaminase and xeroderma pigmentosum group D polymorphisms with response, toxicity, and survival in cisplatin/gemcitabine-treated advanced non-small cell lung cancer patients.
Ludovini V; Floriani I; Pistola L; Minotti V; Meacci M; Chiari R; Garavaglia D; Tofanetti FR; Flacco A; Siggillino A; Baldelli E; Tonato M; Crinò L
J Thorac Oncol; 2011 Dec; 6(12):2018-26. PubMed ID: 22052224
[TBL] [Abstract] [Full Text] [Related]
16. Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: a pathway-based analysis.
Dong J; Hu Z; Shu Y; Pan S; Chen W; Wang Y; Hu L; Jiang Y; Dai J; Ma H; Jin G; Shen H
Mol Carcinog; 2012 Jul; 51(7):546-52. PubMed ID: 21739480
[TBL] [Abstract] [Full Text] [Related]
17. An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer.
Butkiewicz D; Rusin M; Sikora B; Lach A; Chorąży M
Mol Biol Rep; 2011 Nov; 38(8):5231-41. PubMed ID: 21188533
[TBL] [Abstract] [Full Text] [Related]
18. Assessment of xpd Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.
Liu L; Yuan P; Wu C; Zhang X; Wang F; Guo H; Zhong R; Xu Y; Wu J; Yu D; Wu T; Zhang X; Nie S; Miao X; Lin D
Lung Cancer; 2011 Jul; 73(1):110-5. PubMed ID: 21129812
[TBL] [Abstract] [Full Text] [Related]
19. [Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma].
Podol'skiĭ PN; Datsenko PV; Pan'shin GA; Sotnikov VM; Mel'nik IuD; Ivashin AV; Bozhenko VK
Vopr Onkol; 2009; 55(4):447-50. PubMed ID: 19947368
[TBL] [Abstract] [Full Text] [Related]
20. [Expression of DNA excision repair enzymes and lung cancer prognosis].
Lü B; Zhang X; Zhang J; Wang ZY; Hao QL; Zhou M; Zhou YK
Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):349-51. PubMed ID: 15182505
[TBL] [Abstract] [Full Text] [Related]